FDA Inspection
Cerovene Inc.Cerovene Inc. – FDA Inspection, Mar 23, 2026
Record Details
This FDA Inspection record concerns Cerovene Inc., with an inspection on March 23, 2026, issued by the New York District Office, covering human drugs.
View Company Profile
ID · 05d833d9-e79d-4941-8baa-1d08d52b23af
Inspection Facts
- Inspection number
- 1308838
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Cerovene Inc.
10| Date | Classification | Office | Project area |
|---|---|---|---|
| April 28, 2025 | VAI | New York District Office | Generic Drug Evaluation |
| August 1, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 5, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 6, 2017 | Not classified | New York District Office | |
| February 8, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Cerovene Inc.
- FDA Inspection 1269142 - 2025-04-28
- FDA Inspection 1215341 - 2023-08-01
- FDA Inspection 1074159 - 2018-11-05
- FDA Inspection 1030876 - 2017-11-06
- FDA Inspection 1001439 - 2017-02-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.